VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SCL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SCLStepan Company
$54.65$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSCLFinancials

Stepan Company (SCL) Financials

30Y historyFree accessUpdated daily

Revenue growth remains inconsistent, fluctuating from a 15.4% contraction in 2024Q1 to a modest 1.9% expansion by 2026Q1, while gross margins have compressed to 10.7%.

SCL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue2.34B2.33B2.18B2.33B2.77B2.35B1.87B1.86B1.99B1.93B1.77B1.78B1.93B1.88B1.8B1.84B1.43B1.28B1.6B1.33B1.17B1.08B935.82M784.86M748.54M711.52M698.94M666.8M610.5M581.9M536.6M
Revenue Growth %5.46%6.96%-6.26%-16.14%18.21%25.47%0.59%-6.78%3.58%8.99%-0.56%-7.84%2.47%4.27%-2.14%28.79%12.12%-20.23%20.32%13.42%8.74%15.23%19.23%4.85%5.2%1.8%4.82%9.22%4.91%8.44%1.59%
Cost of Goods Sold2.08B2.06B1.91B2.05B2.35B1.95B1.49B1.52B1.65B1.59B1.43B1.47B1.68B1.6B1.51B1.59B1.2B1.04B1.43B1.19B1.05B955.51M824.85M681.12M626.01M604.29M547.63M506.3M461.6M442.5M408.3M
COGS % of Revenue-88.43%87.51%88.06%84.6%83.13%79.48%81.72%82.87%82.43%80.83%82.65%87.05%85.02%83.84%86.13%83.51%81.74%89.4%89.37%89.27%88.61%88.14%86.78%83.63%84.93%78.35%75.93%75.61%76.04%76.09%
Gross Profit259.28M269.89M272.21M277.6M427.07M395.81M383.61M339.71M341.5M338.26M338.55M308.24M249.56M281.69M291.55M255.55M235.98M233.1M169.54M141.4M125.79M122.86M110.97M103.74M122.53M107.23M151.3M160.5M148.9M139.4M128.3M
Gross Margin %11.06%11.57%12.49%11.94%15.4%16.87%20.52%18.28%17.13%17.57%19.17%17.35%12.95%14.98%16.16%13.87%16.49%18.26%10.6%10.63%10.73%11.39%11.86%13.22%16.37%15.07%21.65%24.07%24.39%23.96%23.91%
Gross Profit Growth %--0.85%-1.94%-35%7.9%3.18%12.92%-0.52%0.96%-0.08%9.83%23.51%-11.4%-3.38%14.09%8.3%1.23%37.49%19.9%12.41%2.38%10.72%6.97%-15.33%14.27%-29.13%-5.73%7.79%6.81%8.65%0.39%
Operating Expenses202.37M200.51M201.73M218.99M219.73M225.03M212.09M212.45M187.5M191.33M205.29M188.31M154.86M171.49M162.84M137.1M128.08M128.22M117.25M110.49M109.93M97.39M91.79M93.94M88.6M76.4M119.28M118.7M103.5M95.1M87.9M
OpEx % of Revenue-8.6%9.25%9.42%7.92%9.59%11.34%11.43%9.4%9.94%11.62%10.6%8.04%9.12%9.03%7.44%8.95%10.05%7.33%8.31%9.38%9.03%9.81%11.97%11.84%10.74%17.07%17.8%16.95%16.34%16.38%
Selling, General & Admin139.51M139.56M143.91M141.57M161.21M152.09M142.91M139.53M135.56M129.71M131.79M131.57M121.31M115.19M117.12M96.57M89.77M91.72M82.82M75.57M80.3M67.81M65.82M69.22M63.7M53.53M57.32M56.6M45.2M39.4M36.1M
SG&A % of Revenue-5.98%6.6%6.09%5.81%6.48%7.64%7.51%6.8%6.74%7.46%7.41%6.29%6.12%6.49%5.24%6.27%7.19%5.18%5.68%6.85%6.29%7.03%8.82%8.51%7.52%8.2%8.49%7.4%6.77%6.73%
Research & Development59.62M59.28M55.67M59.04M66.63M62.69M57.99M55.04M54.26M53.87M56.09M50.24M45.45M46.81M45.71M40.52M38.31M36.49M34.44M31.46M29.64M29.59M25.97M24.72M24.9M22.87M22.68M22.6M21M20.4M19.7M
R&D % of Revenue-2.54%2.55%2.54%2.4%2.67%3.1%2.96%2.72%2.8%3.18%2.83%2.36%2.49%2.53%2.2%2.68%2.86%2.15%2.37%2.53%2.74%2.77%3.15%3.33%3.21%3.24%3.39%3.44%3.51%3.67%
Other Operating Expenses2.47M1.67M2.15M18.38M-8.11M10.25M11.2M17.88M-725K3.32M828K1.58M1.29M2.17M1.33M00003.47M00000039.28M39.5M37.3M35.3M32.1M
Operating Income56.91M69.38M70.48M58.61M207.34M170.78M171.52M127.26M151.42M154.84M126.19M122.79M90.69M109.15M128.72M118.46M107.9M104.89M70.68M35.09M15.85M25.47M19.18M9.8M33.93M30.83M32.03M41.8M45.4M44.3M40.4M
Operating Margin %2.43%2.98%3.23%2.52%7.48%7.28%9.17%6.85%7.59%8.04%7.14%6.91%4.71%5.8%7.14%6.43%7.54%8.22%4.42%2.64%1.35%2.36%2.05%1.25%4.53%4.33%4.58%6.27%7.44%7.61%7.53%
Operating Income Growth %--1.56%20.25%-71.73%21.4%-0.43%34.78%-15.96%-2.21%22.7%2.77%35.39%-16.91%-15.2%8.66%9.79%2.87%48.4%101.4%121.38%-37.75%32.79%95.78%-71.13%10.05%-3.73%-23.38%-7.93%2.48%9.65%23.17%
EBITDA186.68M195.42M182.68M163.95M301.99M261.66M253.38M205.96M232.53M233.86M201.16M189.78M154.5M165.55M180.01M165.56M148.25M142.06M107.61M72.27M54.24M64.24M58.35M51.22M74.05M70.8M71.31M81.3M82.7M79.6M72.5M
EBITDA Margin %7.97%8.38%8.38%7.05%10.89%11.15%13.55%11.08%11.66%12.15%11.39%10.68%8.02%8.8%9.98%8.98%10.36%11.13%6.73%5.43%4.63%5.96%6.24%6.53%9.89%9.95%10.2%12.19%13.55%13.68%13.51%
EBITDA Growth %-3%6.98%11.42%-45.71%15.41%3.27%23.02%-11.43%-0.57%16.26%6%22.83%-6.68%-8.03%8.73%11.67%4.36%32.02%48.9%33.25%-15.57%10.09%13.91%-30.83%4.58%-0.7%-12.29%-1.69%3.89%9.79%14.72%
D&A (Non-Cash Add-back)129.77M126.04M112.2M105.34M94.65M90.88M81.86M78.7M81.11M79.02M74.97M66.98M63.8M56.4M51.29M47.1M40.35M37.17M36.93M37.18M38.38M38.77M39.17M41.43M40.12M39.97M39.28M39.5M37.3M35.3M32.1M
EBIT10.16M86.13M79.9M64.34M199.59M179.54M178.65M137.55M150.64M160.4M128.27M117.61M87.24M106.05M125.43M114.35M108.26M103.4M64.39M30.91M15.85M25.47M19.18M9.8M33.93M31.23M32.03M41.8M45.4M44.3M40.4M
Net Interest Income-19.99M-22.11M-14.18M-12.1M-9.81M-5.75M-5.41M-5.93M-10.77M-11.44M-13.21M-14.53M-11.44M-10.36M-9.6M-9.1M-6.34M-6.27M-9.51M000000000000
Interest Income121K4.11M5.28M3.84M1.08M1.25M2.17M5.72M1.83M2.08M1.25M217K262K57K112K359K439K0284K000000000000
Interest Expense20.11M26.23M19.46M15.95M10.89M7.01M7.58M11.65M12.6M13.52M14.45M14.75M11.7M10.41M9.71M9.45M6.78M6.27M9.8M000000000000
Other Income/Expense-76.16M-9.48M-10.04M-10.22M-18.63M1.76M-455K-1.36M-11.5M-15.6M-14.01M-19.93M-15.16M-13.52M-12.99M-13.56M-6.42M-7.76M-15.8M-11.38M-8.46M-7.82M-4.55M-4.53M-3.66M-5.3M-7.63M-7M-6.6M-9.4M-8.1M
Pretax Income-19.25M59.9M60.44M48.39M188.7M172.54M171.07M125.9M137.77M139.24M113.82M102.86M75.53M95.63M115.72M104.89M101.48M97.13M54.88M23.71M7.39M17.65M14.63M5.27M30.27M25.93M24.4M34.8M38.8M34.9M32.3M
Pretax Margin %-0.82%2.57%2.77%2.08%6.8%7.35%9.15%6.77%6.91%7.23%6.44%5.79%3.92%5.08%6.42%5.69%7.09%7.61%3.43%1.78%0.63%1.64%1.56%0.67%4.04%3.64%3.49%5.22%6.36%6%6.02%
Income Tax-5.03M13.01M10.07M8.19M41.55M34.64M43.41M22.8M26.66M47.69M27.62M26.82M18.45M23.29M36.03M32.29M35.89M34.03M17.61M8.69M900K4.17M4.32M360K10.14M9.73M9.39M12.7M15.3M14.5M13.2M
Effective Tax Rate %26.12%21.72%16.66%16.92%22.02%20.08%25.38%18.11%19.35%34.25%24.27%26.07%24.43%24.36%31.14%30.79%35.36%35.03%32.1%36.63%12.18%23.63%29.52%6.83%33.5%37.51%38.5%36.49%39.43%41.55%40.87%
Net Income-14.22M46.9M50.37M40.2M147.15M137.8M126.77M103.13M112.76M91.58M86.19M75.97M57.1M72.83M79.4M71.98M65.43M63.05M37.17M15.12M6.67M13.16M10.32M4.91M20.13M16.07M15.01M22.1M23.5M20.4M19.1M
Net Margin %-0.61%2.01%2.31%1.73%5.31%5.87%6.78%5.55%5.66%4.76%4.88%4.28%2.96%3.87%4.4%3.91%4.57%4.94%2.32%1.14%0.57%1.22%1.1%0.63%2.69%2.26%2.15%3.31%3.85%3.51%3.56%
Net Income Growth %-125.31%-6.9%25.29%-72.68%6.78%8.7%22.92%-8.54%23.13%6.25%13.46%33.04%-21.59%-8.27%10.31%10.01%3.77%69.61%145.88%126.66%-49.31%27.46%110.22%-75.6%25.24%7.09%-32.09%-5.96%15.2%6.81%18.63%
Net Income (Continuing)-14.22M46.9M50.37M40.2M147.15M137.9M127.66M103.1M111.11M91.55M86.2M76.04M57.08M72.34M79.69M72.6M65.59M63.1M37.26M15.12M6.49M13.16M10.32M4.91M20.13M16.15M15.01M22.1M23.5M20.4M19.1M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000001.67M713K760K818K1.31M1.4M1.4M1.46M1.9M4.25M3.58M1.14M1.09M676K751K905K934K00000000
EPS (Diluted)-0.622.052.201.756.385.925.454.424.834.313.733.322.493.183.493.212.952.921.760.750.320.680.530.231.020.830.771.111.110.930.86
EPS Growth %-125.2%-6.82%25.71%-72.57%7.77%8.62%23.3%-8.49%12.06%15.55%12.35%33.33%-21.7%-8.88%8.72%8.81%1.03%65.91%134.67%134.38%-52.94%28.3%130.43%-77.45%22.89%7.79%-30.63%0%19.35%8.14%17.81%
EPS (Basic)-2.052.211.776.466.015.524.474.904.393.783.342.513.223.713.443.183.161.910.770.320.690.530.231.090.870.841.181.240.990.90
Diluted Shares Outstanding22.89M22.89M22.93M22.95M23.06M23.29M23.26M23.32M23.32M23.38M23.09M22.86M22.92M22.92M22.73M22.44M22.18M21.59M21.1M20.23M18.57M19.45M18.08M18.17M19.6M19.44M19.62M19.64M21.27M21.93M22.34M
Basic Shares Outstanding22.89M22.87M22.89M22.78M22.78M22.92M22.95M23.05M23.02M22.95M22.79M22.73M22.76M22.62M21.27M20.73M20.33M19.74M19.13M18.63M18.27M18.01M17.94M17.78M17.72M17.67M17.9M18.46M19M20.71M21.22M
Dividend Payout Ratio-74.7%67.4%81.75%20.78%20.38%20.04%22.4%18.5%20.65%20.11%21.46%26.95%19.87%16.07%16%16.16%13.96%21.77%50.56%110.34%53.75%67.13%154.33%36.46%45.73%46.67%30.32%27.23%29.9%30.37%

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Feedstock cost volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Lacks Consistent Momentum

According to quarterly financial data, Stepan's revenue growth has fluctuated significantly, moving from a 15.4% contraction in 2024Q1 to a modest 1.9% expansion by 2026Q1, suggesting that the company struggles to maintain a consistent top-line trajectory amidst shifting demand in its core surfactant and polymer segments.

The erratic revenue performance appears to reflect the company's sensitivity to cyclical end-markets like commercial construction and the inherent volatility of raw material pass-through pricing. Investors should monitor whether the recent return to positive growth is sustainable or merely a reflection of temporary pricing adjustments rather than genuine volume expansion.

Structural Margin Compression Remains Persistent

As reported in recent income statements, Stepan's gross margin has compressed to 10.7% in 2026Q1, highlighting a persistent inability to expand profitability despite its role as a critical supplier to global consumer packaged goods firms, which suggests limited pricing power in a high-volume, commodity-linked processing environment.

The thin gross margin profile indicates that the company functions more as a high-volume processor than a specialty chemical innovator. This structural limitation leaves the firm highly vulnerable to feedstock inflation, as the current margin levels provide little buffer to absorb unexpected cost spikes without immediate and full price pass-throughs.

Operating Leverage Constrained by Costs

Based on the provided financial figures, operating income has failed to scale effectively with revenue, reaching only 2.6% in 2026Q1, which suggests that the company's fixed cost base remains heavy relative to its current gross profit generation, limiting the potential for meaningful operating leverage during periods of revenue growth.

The inability to drive significant operating margin expansion during revenue-positive quarters warrants further investigation into the company's cost structure. It appears that the firm's operational efficiency is currently hampered by high overheads that do not fluctuate in tandem with top-line performance, potentially signaling a need for structural cost rationalization.

Net Income Volatility Masks Performance

Data from recent filings reveals that Stepan's net income has experienced extreme volatility, including a net loss of $41.4 million in 2026Q1, which suggests that non-operating items or tax anomalies may be significantly distorting the underlying quality of earnings reported to shareholders in any given quarter.

The wide variance between operating income and net income indicates that investors should look beyond headline EPS to understand the core business health. The recent net loss, despite positive operating income, suggests that external factors or accounting adjustments are creating noise that obscures the true operational performance of the surfactant and polymer divisions.

Commodity Exposure Risks Margin Stability

Based on the reported 2.98% operating margin, short-sellers may focus on the company's extreme sensitivity to feedstock price volatility, as the thin profitability buffer suggests that any sustained increase in raw material costs could rapidly erode the firm's ability to generate positive net income for shareholders.

The market's tendency to view Stepan as a defensive consumer staple play may be misplaced given its heavy reliance on volatile commodity inputs. If the company cannot successfully navigate the lag between raw material price changes and contract adjustments, the risk of further margin compression appears significant and warrants a cautious outlook.

SCL — Frequently Asked Questions

Quick answers to the most common questions about buying SCL stock.

What was Stepan Company's (SCL) revenue in 2025?

For fiscal year 2025, Stepan Company (SCL) reported total revenue of $2.33B. This represents a 334.6% increase compared to $536.6M in 1996.

Is Stepan Company (SCL) profitable?

Stepan Company (SCL) is profitable, generating $46.9M in net income for the fiscal year ending 2025 with a net profit margin of 2.0%.

What is Stepan Company's operating profit margin?

Stepan Company (SCL) reported an operating income of $69.4M, resulting in an operating profit margin of 3.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Stepan Company's gross profit and gross margin?

Stepan Company (SCL) generated $269.9M in gross profit for the year, representing a gross profit margin of 11.6%. This demonstrates the company's core pricing power and production efficiency.